IPX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Iperionx Ltd (IPX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks immediate positive catalysts, has bearish technical indicators, and no significant trading signals. While analysts maintain a Buy rating, the company's revenue generation is delayed, and financial performance is unclear due to missing data. It is better to wait for clearer signs of growth or improved technical and financial performance before investing.
The technical indicators for IPX are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 20.789, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 22.325 and resistance at 28.953.
Analysts maintain a Buy rating, and the company's capacity expansion remains on track for mid-2027, supported by government funding.
Revenue generation has been delayed to the second half of 2026, and the company is burning $8M-$9M in cash quarterly. There are no significant hedge fund or insider trading trends, and no recent news or congress trading data to act as a catalyst.
No financial data is available for analysis. The company's latest quarter financials could not be assessed.
Roth Capital and B. Riley both lowered their price targets recently, citing delays in revenue generation and ambitious EBITDA targets. However, both maintain a Buy rating on the stock.
